Referências
Principais artigos
National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Apr 2022 [internet publication].Texto completo
Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD001770.Texto completo Resumo
Go CY, Mackay MT, Weiss SK, et al; Child Neurology Society; American Academy of Neurology. Evidence-based guideline update: medical treatment of infantile spasms. Neurology. 2012 Jun 12;78(24):1974-80.Texto completo Resumo
Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005 Nov;4(11):712-7. Resumo
Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia. 2009 Feb;50(2):163-73. Resumo
Artigos de referência
1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989 Jul-Aug;30(4):389-99. Resumo
2. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010 Apr;51(4):676-85.Texto completo Resumo
3. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.Texto completo Resumo
4. RamachandranNair R, Ochi A, Akiyama T, et al. Partial seizures triggering infantile spasms in the presence of a basal ganglia glioma. Epileptic Disord. 2005 Dec;7(4):378-82. Resumo
5. Drury I, Beydoun A, Garofalo EA, et al. Asymmetric hypsarrhythmia: clinical electroencephalographic and radiological findings. Epilepsia. 1995 Jan;36(1):41-7. Resumo
6. Cowan LD, Hudson LS. The epidemiology and natural history of infantile spasms. J Child Neurol. 1991 Oct;6(4):355-64. Resumo
7. Sidenvall R, Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia. 1995 Jun;36(6):572-4. Resumo
8. Riikonen R, Donner M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland. Dev Med Child Neurol. 1979 Jun;21(3):333-43. Resumo
9. Kalra V, Gulati S, Pandey RM, et al. West syndrome and other infantile epileptic encephalopathies: Indian hospital experience. Brain Dev. 2002 Mar;24(2):130-9. Resumo
10. Matsuo A, Matsuzaka T, Tsuru A, et al. Epidemiological and clinical studies of West syndrome in Nagasaki Prefecture, Japan. Brain Dev. 2001 Nov;23(7):575-9. Resumo
11. Cowan LD, Bodensteiner JB, Leviton A, et al. Prevalence of the epilepsies in children and adolescents. Epilepsia. 1989 Jan-Feb;30(1):94-106. Resumo
12. Happ HC, Carvill GL. A 2020 view on the genetics of developmental and epileptic encephalopathies. Epilepsy Curr. 2020 Mar;20(2):90-6.Texto completo Resumo
13. Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol. 2004 Sep;19(9):680-6. Resumo
14. Zeng LL, Luo R, Zhang L. Efficacy of high-dose ACTH versus low-dose ACTH in infantile spasms: a meta-analysis with direct and indirect comparison of randomized trials. J Pediatr Neurol. 2011;9(2):141-9.Texto completo
15. Marsh ED, Golden JA. Developing an animal model for infantile spasms: pathogenesis, problems and progress. Dis Model Mech. 2009 Jul-Aug;2(7-8):329-35.Texto completo Resumo
16. Rosser TL, Acosta MT, Packer RJ. Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pediatr Neurol. 2002 Nov;27(5):343-6. Resumo
17. Ohtsuka Y, Tanaka A, Kobayashi K, et al. Childhood-onset epilepsy associated with polymicrogyria. Brain Dev. 2002 Dec;24(8):758-65. Resumo
18. Mathern GW, Andres M, Salamon N, et al. A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities. Epilepsia. 2007;48 Suppl 5:74-8.Texto completo Resumo
19. Golomb MR, Garg BP, Williams LS. Outcomes of children with infantile spasms after perinatal stroke. Pediatr Neurol. 2006 Apr;34(4):291-5. Resumo
20. Watanabe K. West syndrome: etiological and prognostic aspects. Brain Dev. 1998 Jan;20(1):1-8. Resumo
21. Kaźmierczuk-Skubis ME, Zatorska-Karpuś M, Pac-Kozuchowska E, et al. Non-ketotic hyperglycinemia as the cause of infant seizures: the case study. Ann Univ Mariae Curie Sklodowska Med. 2004;59(1):237-41. Resumo
22. Tsuji M, Kuroki S, Maeda H, et al. Leigh syndrome associated with West syndrome. Brain Dev. 2003 Jun;25(4):245-50. Resumo
23. Shah NS, Mitchell WG, Boles RG. Mitochondrial disorders: a potentially under-recognized etiology of infantile spasms. J Child Neurol. 2002 May;17(5):369-72. Resumo
24. Soman TB, Moharir M, deVeber G, et al. Infantile spasms as an adverse outcome of neonatal cortical sinovenous thrombosis. J Child Neurol. 2006 Feb;21(2):126-31. Resumo
25. Askenasi A, Snead OC 3rd. Infantile spasms secondary to brain tumor. J Child Neurol. 1991 Apr;6(2):180-2. Resumo
26. National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Apr 2022 [internet publication].Texto completo
27. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD001770.Texto completo Resumo
28. Gibbs FA, Gibbs EL. Atlas of encephalography, vol 2: epilepsy, 2nd ed. Cambridge, MA: Addison-Wesley; 1952.
29. Yuskaitis CJ, Ruzhnikov MRZ, Howell KB, et al. Infantile spasms of unknown cause: predictors of outcome and genotype-phenotype correlation. Pediatr Neurol. 2018 Oct;87:48-56.Texto completo Resumo
30. Ko A, Youn SE, Kim SH, et al. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy. Epilepsy Res. 2018 Mar;141:48-55. Resumo
31. Symonds JD, Elliott KS, Shetty J, et al. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Brain. 2021 Oct 22;144(9):2879-91.Texto completo Resumo
32. Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain. 2019 Aug 1;142(8):2303-18.Texto completo Resumo
33. Michaud JL, Lachance M, Hamdan FF, et al. The genetic landscape of infantile spasms. Hum Mol Genet. 2014 Sep 15;23(18):4846-58. Resumo
34. Wolff M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia. 2006;47 Suppl 2:45-8.Texto completo Resumo
35. Vigevano F, Fusco L, Di Capua M, et al. Benign infantile familial convulsions. Eur J Pediatr. 1992 Aug;151(8):608-12. Resumo
36. Paro-Panjan D, Neubauer D. Benign neonatal sleep myoclonus: experience from the study of 38 infants. Eur J Paediatr Neurol. 2008 Jan;12(1):14-8. Resumo
37. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21.Texto completo Resumo
38. Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia. 2010 Oct;51(10):2175-89.Texto completo Resumo
39. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia. 1983 Apr;24(2):135-58. Resumo
40. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics. 1982 Feb;13(1):14-23. Resumo
41. Go CY, Mackay MT, Weiss SK, et al; Child Neurology Society; American Academy of Neurology. Evidence-based guideline update: medical treatment of infantile spasms. Neurology. 2012 Jun 12;78(24):1974-80.Texto completo Resumo
42. O'Callaghan FJ, Edwards SW, Alber FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017 Jan;16(1):33-42.Texto completo Resumo
43. Shumiloff NA, Lam WM, Manasco KB. Adrenocorticotropic hormone for the treatment of West syndrome in children. Ann Pharmacother. 2013 May;47(5):744-54. Resumo
44. Hrachovy RA, Frost JD Jr, Glaze DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr. 1994 May;124(5 pt 1):803-6. Resumo
45. Yanagaki S, Oguni H, Hayashi K, et al. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev. 1999 Oct;21(7):461-7. Resumo
46. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005 Nov;4(11):712-7. Resumo
47. Wanigasinghe J, Arambepola C, Sri Ranganathan S, et al. Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin on immediate and continued spasm control in West syndrome. Pediatr Neurol. 2015 Sep;53(3):193-9.Texto completo Resumo
48. Wanigasinghe J, Arambepola C, Ranganathan SS, et al. Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin: a 12-month assessment of spasm control in West syndrome. Pediatr Neurol. 2017 Nov;76:14-9.Texto completo Resumo
49. Gowda VK, Hiremath R, Gornale V, et al. A randomized controlled trial on the study of effectiveness and safety of hormonal (ACTH) treatment alone versus hormonal (ACTH) with levetiracetam for epileptic spasms. J Neurosci Rural Pract. 2022 Jul;13(3):403-10.Texto completo Resumo
50. Basit A, Noreen N, Saleem SF, et al. Comparison of efficacy and safety of low- versus high-dose oral prednisolone in infantile spasm (IS): an open label randomized controlled trial at the Children's Hospital & Institute of Child Health, Multan, Pakistan. Cureus. 2022 Mar;14(3):e23164.Texto completo Resumo
51. Riikonen R. The latest on infantile spasms. Curr Opin Neurol. 2005 Apr;18(2):91-5. Resumo
52. Hancock E, Osborne JP. Vigabatrin in the treatment of infantile spasms in tuberous scerosis: literature review. J Child Neurol. 1999 Feb;14(2):71-4. Resumo
53. Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999 Nov;40(11):1627-33. Resumo
54. Elterman RD, Shields WD, Bittman RM, et al. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol. 2010 Nov;25(11):1340-7. Resumo
55. You SJ, Ahn H, Ko TS. Vigabatrin and visual field defects in pediatric epilepsy patients. J Korean Med Sci. 2006 Aug;21(4):728-32.Texto completo Resumo
56. Wheless JW, Ramsay RE, Collins SD. Vigabatrin. Neurotherapeutics. 2007 Jan;4(1):163-72. Resumo
57. Spencer EL, Harding GF. Examining visual field defects in the paediatric population exposed to vigabatrin. Doc Ophthalmol. 2003 Nov;107(3):281-7. Resumo
58. Gross-Tsur V, Banin E, Shahar E, et al. Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurol. 2000 Jul;48(1):60-4. Resumo
59. Maguire MJ, Hemming K, Wild JM, et al. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia. 2010 Dec;51(12):2423-31. Resumo
60. Westall CA, Wright T, Cortese F, et al. Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study. Neurology. 2014 Dec 9;83(24):2262-8.Texto completo Resumo
61. Schwarz MD, Li M, Tsao J, et al. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: the UCLA experience. Epilepsy Behav. 2016 Apr;57(Pt A):29-33. Resumo
62. Fong CY, Osborne JP, Edwards SW, et al. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol. 2013 Sep;55(9):862-7. Resumo
63. Hussain SA, Tsao J, Li M, et al. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Epilepsia. 2017 Apr;58(4):674-82.Texto completo Resumo
64. Reyes Valenzuela G, Crespo A, Princich J, et al. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome. Epilepsy Behav. 2022 Apr;129:108606. Resumo
65. Darke K, Edwards SW, Hancock E, et al; trial steering committee on behalf of participating investigators. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child. 2010 May;95(5):382-6. Resumo
66. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004 Nov 13-19;364(9447):1773-8. Resumo
67. Song JM, Hahn J, Kim SH, et al. Efficacy of treatments for infantile spasms: a systematic review. Clin Neuropharmacol. 2017 Mar/Apr;40(2):63-84. Resumo
68. Fallah R, Salor F, Akhavan Karbasi S, et al. Randomised clinical efficacy trial of topiramate and nitrazepam in treatment of infantile spasms. Iran J Child Neurol. 2014 Winter;8(1):12-9. Resumo
69. Prezioso G, Carlone G, Zaccara G, et al. Efficacy of ketogenic diet for infantile spasms: a systematic review. Acta Neurol Scand. 2018 Jan;137(1):4-11. Resumo
70. Dressler A, Benninger F, Trimmel-Schwahofer P, et al. Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: a single-center parallel-cohort randomized controlled trial. Epilepsia. 2019 Mar;60(3):441-51. Resumo
71. Zhang J, Chen G, Wang J, et al. Efficacy of the ketogenic diet on ACTH- or corticosteroid-resistant infantile spasm: a multicentre prospective control study. Epileptic Disord. 2021 Apr 1;23(2):337-45. Resumo
72. Ohtsuka Y, Ogino T, Asano T, et al. Long-term follow-up of vitamin B(6)-responsive West syndrome. Pediatr Neurol. 2000 Sep;23(3):202-6. Resumo
73. Kunnanayaka V, Jain P, Sharma S, et al. Addition of pyridoxine to prednisolone in the treatment of infantile spasms: a pilot, randomized controlled trial. Neurol India. 2018 Mar-Apr;66(2):385-90. Resumo
74. Guerin A, Aziz AS, Mutch C, et al. Pyridox(am)ine-5-phosphate oxidase deficiency treatable cause of neonatal epileptic encephalopathy with burst suppression: case report and review of the literature. J Child Neurol. 2015 Aug;30(9):1218-25. Resumo
75. Chugani HT, Ilyas M, Kumar A, et al. Surgical treatment for refractory epileptic spasms: the Detroit series. Epilepsia. 2015 Dec;56(12):1941-9. Resumo
76. Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia. 2009 Feb;50(2):163-73. Resumo
77. O'Callaghan FJ, Edwards SW, Alber FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017 Jan;16(1):33-42.Texto completo Resumo
78. Riikonen R. Infantile spasms: outcome in clinical studies. Pediatr Neurol. 2020 Jul;108:54-64.Texto completo Resumo
79. Osborne JP, Edwards SW, Dietrich Alber F, et al. The underlying etiology of infantile spasms (West syndrome): information from the International Collaborative Infantile Spasms Study (ICISS). Epilepsia. 2019 Sep;60(9):1861-9. Resumo
80. Granström ML, Gaily E, Liukkonen E. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms. Epilepsia. 1999 Jul;40(7):950-7.Texto completo Resumo
81. Cohen-Sadan S, Kramer U, Ben-Zeev B, et al. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin. Eur J Neurol. 2009 Apr;16(4):482-7. Resumo
82. Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004 Mar;45(3):255-62.Texto completo Resumo
83. Gaily E, Lommi M, Lapatto R, et al. Incidence and outcome of epilepsy syndromes with onset in the first year of life: a retrospective population-based study. Epilepsia. 2016 Oct;57(10):1594-601.Texto completo Resumo
84. Jeavons PM, Bower BD, Dimitrakoudi M. Long-term prognosis of 150 cases of "West syndrome". Epilepsia. 1973 Jun;14(2):153-64. Resumo
85. O'Callaghan FJ, Lux AL, Darke K, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 2011 Jul;52(7):1359-64.Texto completo Resumo
86. Auvin S, Hartman AL, Desnous B, et al. Diagnosis delay in West syndrome: misdiagnosis and consequences. Eur J Pediatr. 2012 Nov;171(11):1695-701. Resumo
87. Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia. 2006 Dec;47(12):2202-5.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal